# Capital Southwest Corp: financial statements, quarterly

CSWC · Nasdaq · CIK 17313 · [Other](/sectors/other.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/cswc.md) · [Financials](/companies/cswc/financials.md) · [Filings](/companies/cswc/filings.md) · [Insiders](/companies/cswc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cswc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [10.5](/filings/0000017313-23-000125.md) | [11.5](/filings/0000017313-24-000006.md) | [11.5 d](/filings/0000017313-24-000022.md) | [12.4](/filings/0000017313-24-000058.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.8)](/filings/0000017313-24-000097.md) | [0.9](/filings/0000017313-25-000012.md) | [0.4 d](/filings/0000017313-26-000035.md) | [2.4](/filings/0000017313-25-000076.md) | [(1.2)](/filings/0000017313-25-000146.md) | [0.4](/filings/0000017313-26-000011.md) | [0.6 d](/filings/0000017313-26-000035.md) | [0.8](/filings/0000017313-26-000095.md) | [2.0](/filings/0000017313-25-000146.md) | [(2.4)](/filings/0000017313-26-000011.md) | [0.6 d](/filings/0000017313-26-000035.md) | [(0.7)](/filings/0000017313-26-000095.md) |
| Net income | $m | [22.6](/filings/0000017313-25-000042.md) | [23.5](/filings/0000017313-25-000042.md) | [13.5](/filings/0000017313-25-000042.md) | [14.0](/filings/0000017313-26-000035.md) | [22.7](/filings/0000017313-26-000035.md) | [16.3](/filings/0000017313-26-000035.md) | [17.6](/filings/0000017313-26-000035.md) | [27.0](/filings/0000017313-26-000095.md) | [25.6](/filings/0000017313-26-000035.md) | [32.9](/filings/0000017313-26-000035.md) | [27.5](/filings/0000017313-26-000035.md) | [24.7](/filings/0000017313-26-000095.md) |
| Diluted EPS | $ per share | [0.69](/filings/0000017313-24-000097.md) | [0.70](/filings/0000017313-24-000022.md) | [0.67](/filings/0000017313-24-000022.md) | [0.31](/filings/0000017313-25-000076.md) | [0.48](/filings/0000017313-25-000146.md) | [0.34](/filings/0000017313-26-000011.md) | not reported | [0.48](/filings/0000017313-26-000095.md) | [0.44](/filings/0000017313-25-000146.md) | [0.54](/filings/0000017313-26-000011.md) | not reported | [0.39](/filings/0000017313-26-000095.md) |
| Basic EPS | $ per share | [0.69](/filings/0000017313-25-000042.md) | [0.70](/filings/0000017313-25-000042.md) | [0.67](/filings/0000017313-25-000042.md) | [0.31](/filings/0000017313-25-000076.md) | [0.48](/filings/0000017313-25-000146.md) | [0.34](/filings/0000017313-26-000011.md) | [0.54](/filings/0000017313-25-000042.md) | [0.50](/filings/0000017313-26-000095.md) | [0.46](/filings/0000017313-25-000146.md) | [0.57](/filings/0000017313-26-000011.md) | not reported | [0.40](/filings/0000017313-26-000095.md) |

- Revenue: not reported
- Gross profit: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [23.0](/filings/0000017313-23-000125.md) | [23.6](/filings/0000017313-24-000006.md) | [32.3](/filings/0000017313-26-000035.md) | [33.3](/filings/0000017313-25-000076.md) | [47.2](/filings/0000017313-25-000146.md) | [36.0](/filings/0000017313-26-000011.md) | [43.2](/filings/0000017313-26-000035.md) | [46.9](/filings/0000017313-26-000095.md) | [87.4](/filings/0000017313-25-000146.md) | [42.6](/filings/0000017313-26-000011.md) | [29.0](/filings/0000017313-26-000095.md) | [58.5](/filings/0000017313-26-000095.md) |
| Total assets | $m | [1,417](/filings/0000017313-23-000125.md) | [1,429](/filings/0000017313-24-000006.md) | [1,557](/filings/0000017313-25-000042.md) | [1,544](/filings/0000017313-24-000058.md) | [1,604](/filings/0000017313-24-000097.md) | [1,789](/filings/0000017313-25-000012.md) | [1,883](/filings/0000017313-26-000035.md) | [1,882](/filings/0000017313-25-000076.md) | [2,021](/filings/0000017313-25-000146.md) | [2,116](/filings/0000017313-26-000011.md) | [2,178](/filings/0000017313-26-000095.md) | [2,316](/filings/0000017313-26-000095.md) |
| Total liabilities | $m | [759](/filings/0000017313-23-000125.md) | [709](/filings/0000017313-24-000006.md) | [801](/filings/0000017313-25-000042.md) | [767](/filings/0000017313-24-000058.md) | [813](/filings/0000017313-24-000097.md) | [959](/filings/0000017313-25-000012.md) | [999](/filings/0000017313-26-000035.md) | [966](/filings/0000017313-25-000076.md) | [1,074](/filings/0000017313-25-000146.md) | [1,120](/filings/0000017313-26-000011.md) | [1,167](/filings/0000017313-26-000095.md) | [1,257](/filings/0000017313-26-000095.md) |
| Long-term debt | $m | [733](/filings/0000017313-23-000125.md) | [678](/filings/0000017313-24-000006.md) | [771](/filings/0000017313-25-000042.md) | [735](/filings/0000017313-24-000058.md) | [785](/filings/0000017313-24-000097.md) | [920](/filings/0000017313-25-000012.md) | [956](/filings/0000017313-26-000035.md) | [926](/filings/0000017313-25-000076.md) | [1,035](/filings/0000017313-25-000146.md) | [1,072](/filings/0000017313-26-000011.md) | [1,131](/filings/0000017313-26-000095.md) | [1,221](/filings/0000017313-26-000095.md) |
| Shareholders' equity | $m | [658](/filings/0000017313-25-000012.md) | [721](/filings/0000017313-25-000012.md) | [756](/filings/0000017313-26-000035.md) | [777](/filings/0000017313-26-000011.md) | [791](/filings/0000017313-26-000011.md) | [830](/filings/0000017313-26-000011.md) | [884](/filings/0000017313-26-000095.md) | [916](/filings/0000017313-26-000095.md) | [947](/filings/0000017313-26-000011.md) | [996](/filings/0000017313-26-000011.md) | [1,011](/filings/0000017313-26-000095.md) | [1,058](/filings/0000017313-26-000095.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(48.8) d](/filings/0000017313-24-000097.md) | [18.0 d](/filings/0000017313-25-000012.md) | [(102) d](/filings/0000017313-26-000035.md) | [31.1](/filings/0000017313-25-000076.md) | [(23.8) d](/filings/0000017313-25-000146.md) | [(166) d](/filings/0000017313-26-000011.md) | [(58.7) d](/filings/0000017313-26-000035.md) | [30.5](/filings/0000017313-26-000095.md) | [(71.2) d](/filings/0000017313-25-000146.md) | [(93.6) d](/filings/0000017313-26-000011.md) | [(59.1) d](/filings/0000017313-26-000035.md) | [(80.9)](/filings/0000017313-26-000095.md) |
| Capital expenditure | $m | [0.0 d](/filings/0000017313-24-000097.md) | [0.0 d](/filings/0000017313-25-000012.md) | [0.0 d](/filings/0000017313-26-000035.md) | [0.0](/filings/0000017313-25-000076.md) | [0.5 d](/filings/0000017313-25-000146.md) | [0.7 d](/filings/0000017313-26-000011.md) | [0.4 d](/filings/0000017313-26-000035.md) | [0.1](/filings/0000017313-26-000095.md) | [0.1 d](/filings/0000017313-25-000146.md) | [0.0 d](/filings/0000017313-26-000011.md) | [0.0 d](/filings/0000017313-26-000035.md) | [0.0](/filings/0000017313-26-000095.md) |
| Dividends paid | $m | [24.8 d](/filings/0000017313-24-000097.md) | [26.9 d](/filings/0000017313-25-000012.md) | [28.4 d](/filings/0000017313-26-000035.md) | [29.5](/filings/0000017313-25-000076.md) | [30.5 d](/filings/0000017313-25-000146.md) | [31.5 d](/filings/0000017313-26-000011.md) | [33.7 d](/filings/0000017313-26-000035.md) | [35.3](/filings/0000017313-26-000095.md) | [36.0 d](/filings/0000017313-25-000146.md) | [37.3 d](/filings/0000017313-26-000011.md) | [38.5 d](/filings/0000017313-26-000035.md) | [39.6](/filings/0000017313-26-000095.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.0](/filings/0000017313-23-000125.md) | [31.4](/filings/0000017313-24-000006.md) | [37.6](/filings/0000017313-24-000058.md) | [39.7](/filings/0000017313-24-000097.md) | [41.5](/filings/0000017313-25-000012.md) | [45.7](/filings/0000017313-25-000076.md) | [47.2](/filings/0000017313-25-000146.md) | [54.1](/filings/0000017313-26-000011.md) | [62.8](/filings/0000017313-26-000095.md) | [64.8](/filings/0000017313-25-000146.md) | [66.8](/filings/0000017313-26-000011.md) | [70.5](/filings/0000017313-26-000095.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 63,733,867 at 2026-07-30, from the cover of the [10-Q filed 2026-08-03](/filings/0000017313-26-000095.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.